期刊文献+

不同波长激光治疗重度非增生型糖尿病视网膜病变的疗效观察 被引量:5

Clinical observation of different wavelength laser in the treatment of severe non-proliferative diabetic retinopathy
下载PDF
导出
摘要 目的比较577 nm、532 nm激光全视网膜激光光凝(panretinal photocoagulation,PRP)治疗重度非增生型糖尿病视网膜病变(non-proliferative diabetic retinopathy,NPDR)的临床疗效。方法前瞻性临床对照研究。纳入重度NPDR患者42例64眼,随机分为577 nm组和532 nm组,采用单点模式行PRP,术前及术后1 d、1个月、3个月、6个月检查最佳矫正视力(best corrected visual acuity,BCVA)、眼底、光学相干断层扫描(optical coherence tomography,OCT)、全视野闪光视网膜电图(flash electroretinogram,F-ERG),术后3个月、6个月行眼底荧光血管造影(fundus fluorescein angiography,FFA)检查。结果 577 nm组和532nm组光斑点数分别为(1969.25±278.19)点、(2098.16±289.27)点;激光功率分别为(425.23±50.15)m W、(438.15±38.48)m W;能量密度分别为(7.54±1.54)m W·ms-1·μm-2、(7.68±3.01)m W·ms-1·μm-2,平均光斑数(t=2.68)、平均激光功率(t=1.46)、平均能量密度(t=2.15)的组间差异均无统计学意义(均为P>0.05)。两组患者术后1个月、3个月、6个月,组间黄斑中心凹厚度(central macular thickness,CMT)差异均无统计学意义(t=1.98、1.88、1.81,均为P>0.05);两组患者术后1个月、3个月、6个月F-ERG振幅(a波:t=5.94、5.19、6.97;b波:t=5.67、4.56、5.12)组间差异均有统计学意义(均为P<0.05)。术后6个月两组患者治疗有效率分别为87.5%、46.9%,差异有统计学意义(χ2=7.56,P<0.05)。结论 577 nm激光比532nm激光治疗重度NPDR有效率更高,视功能损伤程度更小。 Objective To compare the clinical effects of 577 nm and 532 nm la- ser panretinal photocoagnlation in the treatment of severe non-proliferative diabetic reti- nopathy (NPDR). Methods A prospective, controlled trial was conducted in 42 pa- tients(64 eyes)with severe NPDR,who were randomly divided into 577 nm group and 532 nm group. All of patients received PRP with the single-point model. Preoperative and postoperative 1 day,1 month,3 and 6 months,the best corrected visual acuity (BC- VA), fundus, optical coherence tomography (OCT) and full field flash electroretinogram (F-ERG) were examined. After treatment 3 and 6 months, fundus fluorescein angiogra- play (FFA) examination was performed between two groups. Results In 577 nm group and 532 nm group ,the average number of laser spot was ( 1969.25 ± 278.19) and (2098.16 ± 289.27) respectively; average laser power was (425.23 ± 50.15 ) mW and (438.15 ± 38.48)mW respectively;and average energy density was (7.54 ± 1.54) mW· ms^-1 μm^-2 and (7.68±3.01)mW · ms · μm 2. There was no difference in num- ber of laser spot( t = 2.68 ), laser power ( t = 1.46) and energy density ( t = 2. 15 ) be- tween the two groups ( all P 〉 0.05 ), and the differences of macular central thickness after treatment 1 month,3 and 6 months ( t = 1.98,1.88,1.81 respectively) approached no statistical significance between the two groups ( all P 〉 0.05 ), while F-ERG a, b wave amplitudes after treatment 1 month, 3 and 6 months ( a wave : t = 5.94,5. 19,6. 97 ; b wave : t = 5.67,4.56,5. 12 ) had significant differences between groups ( all P 〈 0.05 ). The effective rate of treating 6 months after operation in the two groups were 87.5% and 46.9% respectively,with significant difference (X^2 = 7.56 ,P 〈 0.05 ). Conclusion 577 nm laser is more effective and has less damage to visual function than 532 nm laser in the treatment of NPDR.
出处 《眼科新进展》 CAS 北大核心 2017年第9期842-845,共4页 Recent Advances in Ophthalmology
基金 四川省教育厅基金项目(编号:15SB0113)~~
关键词 糖尿病视网膜病变 激光光凝术:全视网膜激光光凝 diabetic retinopathy laser coagulation wavelength
  • 相关文献

参考文献1

二级参考文献17

  • 1Fong DS,Ferris FL 3rd, Davis MD, et al. Early Treatment Diabetic Retinopathy Study Research Group. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24 [J]. Am J Ophthalmol,1999,127(2) :137-141.
  • 2Alghadyan AA. Diabetic retinopathy-an update [J]. Saudi J Ophthalmol, 2011,25(2): 99-111.
  • 3Shah AM, Bressler NM, Jampol LM. Does laser still have a role in the management of retinal vascular and neovascular diseases? [J] Am J Ophthalmol, 2011, 152 (3): 332-339.
  • 4Sramek CK, Leung LS, Paulus YM, et al. Therapeutic window of retinal photocoagulation with green (532-nm) and yellow (577-nm) lasers [J]. Ophthalmic Surg Lasers Imaging, 2012,43 (4) :341-347.
  • 5Kwon YH, Lee DK, Kwon OW. The short-term efficacy of subthreshold Micropulse yellow (577-nm) laser photocoagulation for diabetic macular edema [J].Korean J Ophthalmol,:2014,28 (5) :379-385.
  • 6Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factor for progression of diabetic retinopathy: ETDRS report number 12 [J]. Ophthalmology, 1991,98(5 Suppt) :S823-833.
  • 7Wilkinson CP,Ferris FL, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales [J]. Ophthalmology, 2003,110(9) :1676-1682.
  • 8Perente I, Alkin Z, Ozkaya A, et al. Focal laser photocoagulation in non-center involved diabetic macular edema[J]. Med Hypothesis Discov Innov Ophthalmol, 2014,3 (1) : 9-16.
  • 9Tso MOM. Retinal photoeoagulation therapy: clinical application and biological basis of therapeutic effects [M]// Tso MOM . Retinal disease. Philadelphia, Philadelphia JB Lippincott Company, 1988 : 247-250.
  • 10The Early Treatment Diabetic Retinopathy Study Research Group. Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report no. 3 [J]. Int Ophthalmol Clin, 1987, 27(4), 254-264.

共引文献46

同被引文献40

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部